Global Copovidone VA 64 Market Research Report 2026(Status and Outlook)

March 2026 | 134 pages | ID: GBADB9A7DF13EN
Bosson Research

US$ 2,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Copovidone VA 64 competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.Copovidone VA 64 (also known as PVP/VA64) is a water-soluble polymer resin copolymerized from N-vinylpyrrolidone (NVP) and vinyl acetate (VA), commonly used as a pharmaceutical excipient and cosmetic ingredient. It possesses excellent adhesion, film-forming properties, plasticity, and low hygroscopicity, making it a multifunctional material.The core raw materials include N-vinylpyrrolidone (NVP) and vinyl acetate (VA). NVP is a complex fine chemical, typically synthesized from butanediol and acetylene/ammonia. VA is produced by reacting ethylene with acetic acid.Global sales in 2024 were approximately 2,710 tons, with an average market price of approximately US$26/kg. The size of a single production line varies depending on the production process and investment scale. Industry gross profit margins range from 20% to 35%.

The global Copovidone VA 64 market size was estimated at USD 70.5 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.20% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Copovidone VA 64 market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Copovidone VA 64 market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Copovidone VA 64 market.

Global Copovidone VA 64 Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

BASF
JRS Pharma
JH Nanhang Life Sciences
Huangshan Bonsun Pharmaceutical
Boai NKY
Jiaozuo Zhongwei Special Products Pharmaceutical
Henan Pengfei New Materials
Shanxi Jinyang Pharmaceutical Excipients

Market Segmentation (by Type)

Powder
Particles

Market Segmentation (by Application)

Adhesives
Film-forming Agents
Other

Geographic Segmentation

North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Copovidone VA 64 Market
Overview of the regional outlook of the Copovidone VA 64 Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Copovidone VA 64 Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Copovidone VA 64, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Copovidone VA
1.2 Key Market Segments
  1.2.1 Copovidone VA 64 Segment by Type
  1.2.2 Copovidone VA 64 Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 COPOVIDONE VA 64 MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Copovidone VA 64 Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Copovidone VA 64 Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 COPOVIDONE VA 64 MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Copovidone VA 64 Product Life Cycle
3.3 Global Copovidone VA 64 Sales by Manufacturers (2020-2025)
3.4 Global Copovidone VA 64 Revenue Market Share by Manufacturers (2020-2025)
3.5 Copovidone VA 64 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Copovidone VA 64 Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Copovidone VA 64 Market Competitive Situation and Trends
  3.8.1 Copovidone VA 64 Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Copovidone VA 64 Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 COPOVIDONE VA 64 INDUSTRY CHAIN ANALYSIS

4.1 Copovidone VA 64 Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF COPOVIDONE VA 64 MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Copovidone VA 64 Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Copovidone VA 64 Market
5.7 ESG Ratings of Leading Companies

6 COPOVIDONE VA 64 MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Copovidone VA 64 Sales Market Share by Type (2020-2025)
6.3 Global Copovidone VA 64 Market Size by Type (2020-2025)
6.4 Global Copovidone VA 64 Price by Type (2020-2025)

7 COPOVIDONE VA 64 MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Copovidone VA 64 Market Sales by Application (2020-2025)
7.3 Global Copovidone VA 64 Market Size (M USD) by Application (2020-2025)
7.4 Global Copovidone VA 64 Sales Growth Rate by Application (2020-2025)

8 COPOVIDONE VA 64 MARKET SALES BY REGION

8.1 Global Copovidone VA 64 Sales by Region
  8.1.1 Global Copovidone VA 64 Sales by Region
  8.1.2 Global Copovidone VA 64 Sales Market Share by Region
8.2 Global Copovidone VA 64 Market Size by Region
  8.2.1 Global Copovidone VA 64 Market Size by Region
  8.2.2 Global Copovidone VA 64 Market Size by Region
8.3 North America
  8.3.1 North America Copovidone VA 64 Sales by Country
  8.3.2 North America Copovidone VA 64 Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Copovidone VA 64 Sales by Country
  8.4.2 Europe Copovidone VA 64 Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Copovidone VA 64 Sales by Region
  8.5.2 Asia Pacific Copovidone VA 64 Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Copovidone VA 64 Sales by Country
  8.6.2 South America Copovidone VA 64 Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Copovidone VA 64 Sales by Region
  8.7.2 Middle East and Africa Copovidone VA 64 Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 COPOVIDONE VA 64 MARKET PRODUCTION BY REGION

9.1 Global Production of Copovidone VA 64 by Region(2020-2025)
9.2 Global Copovidone VA 64 Revenue Market Share by Region (2020-2025)
9.3 Global Copovidone VA 64 Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Copovidone VA 64 Production
  9.4.1 North America Copovidone VA 64 Production Growth Rate (2020-2025)
  9.4.2 North America Copovidone VA 64 Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Copovidone VA 64 Production
  9.5.1 Europe Copovidone VA 64 Production Growth Rate (2020-2025)
  9.5.2 Europe Copovidone VA 64 Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Copovidone VA 64 Production (2020-2025)
  9.6.1 Japan Copovidone VA 64 Production Growth Rate (2020-2025)
  9.6.2 Japan Copovidone VA 64 Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Copovidone VA 64 Production (2020-2025)
  9.7.1 China Copovidone VA 64 Production Growth Rate (2020-2025)
  9.7.2 China Copovidone VA 64 Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 BASF
  10.1.1 BASF Basic Information
  10.1.2 BASF Copovidone VA 64 Product Overview
  10.1.3 BASF Copovidone VA 64 Product Market Performance
  10.1.4 BASF Business Overview
  10.1.5 BASF SWOT Analysis
  10.1.6 BASF Recent Developments
10.2 JRS Pharma
  10.2.1 JRS Pharma Basic Information
  10.2.2 JRS Pharma Copovidone VA 64 Product Overview
  10.2.3 JRS Pharma Copovidone VA 64 Product Market Performance
  10.2.4 JRS Pharma Business Overview
  10.2.5 JRS Pharma SWOT Analysis
  10.2.6 JRS Pharma Recent Developments
10.3 JH Nanhang Life Sciences
  10.3.1 JH Nanhang Life Sciences Basic Information
  10.3.2 JH Nanhang Life Sciences Copovidone VA 64 Product Overview
  10.3.3 JH Nanhang Life Sciences Copovidone VA 64 Product Market Performance
  10.3.4 JH Nanhang Life Sciences Business Overview
  10.3.5 JH Nanhang Life Sciences SWOT Analysis
  10.3.6 JH Nanhang Life Sciences Recent Developments
10.4 Huangshan Bonsun Pharmaceutical
  10.4.1 Huangshan Bonsun Pharmaceutical Basic Information
  10.4.2 Huangshan Bonsun Pharmaceutical Copovidone VA 64 Product Overview
  10.4.3 Huangshan Bonsun Pharmaceutical Copovidone VA 64 Product Market Performance
  10.4.4 Huangshan Bonsun Pharmaceutical Business Overview
  10.4.5 Huangshan Bonsun Pharmaceutical Recent Developments
10.5 Boai NKY
  10.5.1 Boai NKY Basic Information
  10.5.2 Boai NKY Copovidone VA 64 Product Overview
  10.5.3 Boai NKY Copovidone VA 64 Product Market Performance
  10.5.4 Boai NKY Business Overview
  10.5.5 Boai NKY Recent Developments
10.6 Jiaozuo Zhongwei Special Products Pharmaceutical
  10.6.1 Jiaozuo Zhongwei Special Products Pharmaceutical Basic Information
  10.6.2 Jiaozuo Zhongwei Special Products Pharmaceutical Copovidone VA 64 Product Overview
  10.6.3 Jiaozuo Zhongwei Special Products Pharmaceutical Copovidone VA 64 Product Market Performance
  10.6.4 Jiaozuo Zhongwei Special Products Pharmaceutical Business Overview
  10.6.5 Jiaozuo Zhongwei Special Products Pharmaceutical Recent Developments
10.7 Henan Pengfei New Materials
  10.7.1 Henan Pengfei New Materials Basic Information
  10.7.2 Henan Pengfei New Materials Copovidone VA 64 Product Overview
  10.7.3 Henan Pengfei New Materials Copovidone VA 64 Product Market Performance
  10.7.4 Henan Pengfei New Materials Business Overview
  10.7.5 Henan Pengfei New Materials Recent Developments
10.8 Shanxi Jinyang Pharmaceutical Excipients
  10.8.1 Shanxi Jinyang Pharmaceutical Excipients Basic Information
  10.8.2 Shanxi Jinyang Pharmaceutical Excipients Copovidone VA 64 Product Overview
  10.8.3 Shanxi Jinyang Pharmaceutical Excipients Copovidone VA 64 Product Market Performance
  10.8.4 Shanxi Jinyang Pharmaceutical Excipients Business Overview
  10.8.5 Shanxi Jinyang Pharmaceutical Excipients Recent Developments

11 COPOVIDONE VA 64 MARKET FORECAST BY REGION

11.1 Global Copovidone VA 64 Market Size Forecast
11.2 Global Copovidone VA 64 Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Copovidone VA 64 Market Size Forecast by Country
  11.2.3 Asia Pacific Copovidone VA 64 Market Size Forecast by Region
  11.2.4 South America Copovidone VA 64 Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Copovidone VA 64 by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Copovidone VA 64 Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Copovidone VA 64 by Type (2026-2035)
  12.1.2 Global Copovidone VA 64 Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Copovidone VA 64 by Type (2026-2035)
12.2 Global Copovidone VA 64 Market Forecast by Application (2026-2035)
  12.2.1 Global Copovidone VA 64 Sales (K MT) Forecast by Application
  12.2.2 Global Copovidone VA 64 Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS


LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Copovidone VA 64 Market Size by Type (M USD)
Table 4. Global Copovidone VA 64 Market Size by Application
Table 5. Copovidone VA 64 Market Size Comparison by Region (M USD)
Table 6. Global Copovidone VA 64 Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Copovidone VA 64 Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Copovidone VA 64 Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Copovidone VA 64 Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Copovidone VA 64 as of 2025)
Table 11. Global Market Copovidone VA 64 Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Copovidone VA 64 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Copovidone VA 64 Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Copovidone VA 64 Sales by Type (K MT)
Table 27. Global Copovidone VA 64 Market Size by Type (M USD)
Table 28. Global Copovidone VA 64 Sales (K MT) by Type (2020-2025)
Table 29. Global Copovidone VA 64 Sales Market Share by Type (2020-2025)
Table 30. Global Copovidone VA 64 Market Size (M USD) by Type (2020-2025)
Table 31. Global Copovidone VA 64 Market Share by Type (2020-2025)
Table 32. Global Copovidone VA 64 Price (USD/KG) by Type (2020-2025)
Table 33. Global Copovidone VA 64 Sales (K MT) by Application
Table 34. Global Copovidone VA 64 Market Size by Application
Table 35. Global Copovidone VA 64 Sales by Application (2020-2025) & (K MT)
Table 36. Global Copovidone VA 64 Sales Market Share by Application (2020-2025)
Table 37. Global Copovidone VA 64 Market Size by Application (2020-2025) & (M USD)
Table 38. Global Copovidone VA 64 Market Share by Application (2020-2025)
Table 39. Global Copovidone VA 64 Sales Growth Rate by Application (2020-2025)
Table 40. Global Copovidone VA 64 Sales by Region (2020-2025) & (K MT)
Table 41. Global Copovidone VA 64 Sales Market Share by Region (2020-2025)
Table 42. Global Copovidone VA 64 Market Size by Region (2020-2025) & (M USD)
Table 43. Global Copovidone VA 64 Market Size by Region (2020-2025)
Table 44. North America Copovidone VA 64 Sales by Country (2020-2025) & (K MT)
Table 45. North America Copovidone VA 64 Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Copovidone VA 64 Sales by Country (2020-2025) & (K MT)
Table 47. Europe Copovidone VA 64 Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Copovidone VA 64 Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Copovidone VA 64 Market Size by Region (2020-2025) & (M USD)
Table 50. South America Copovidone VA 64 Sales by Country (2020-2025) & (K MT)
Table 51. South America Copovidone VA 64 Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Copovidone VA 64 Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Copovidone VA 64 Market Size by Region (2020-2025) & (M USD)
Table 54. Global Copovidone VA 64 Production (K MT) by Region(2020-2025)
Table 55. Global Copovidone VA 64 Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Copovidone VA 64 Revenue Market Share by Region (2020-2025)
Table 57. Global Copovidone VA 64 Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Copovidone VA 64 Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Copovidone VA 64 Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Copovidone VA 64 Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Copovidone VA 64 Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. BASF Basic Information
Table 63. BASF Copovidone VA 64 Product Overview
Table 64. BASF Copovidone VA 64 Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. BASF Business Overview
Table 66. BASF SWOT Analysis
Table 67. BASF Recent Developments
Table 68. JRS Pharma Basic Information
Table 69. JRS Pharma Copovidone VA 64 Product Overview
Table 70. JRS Pharma Copovidone VA 64 Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. JRS Pharma Business Overview
Table 72. JRS Pharma SWOT Analysis
Table 73. JRS Pharma Recent Developments
Table 74. JH Nanhang Life Sciences Basic Information
Table 75. JH Nanhang Life Sciences Copovidone VA 64 Product Overview
Table 76. JH Nanhang Life Sciences Copovidone VA 64 Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. JH Nanhang Life Sciences Business Overview
Table 78. JH Nanhang Life Sciences SWOT Analysis
Table 79. JH Nanhang Life Sciences Recent Developments
Table 80. Huangshan Bonsun Pharmaceutical Basic Information
Table 81. Huangshan Bonsun Pharmaceutical Copovidone VA 64 Product Overview
Table 82. Huangshan Bonsun Pharmaceutical Copovidone VA 64 Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Huangshan Bonsun Pharmaceutical Business Overview
Table 84. Huangshan Bonsun Pharmaceutical Recent Developments
Table 85. Boai NKY Basic Information
Table 86. Boai NKY Copovidone VA 64 Product Overview
Table 87. Boai NKY Copovidone VA 64 Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Boai NKY Business Overview
Table 89. Boai NKY Recent Developments
Table 90. Jiaozuo Zhongwei Special Products Pharmaceutical Basic Information
Table 91. Jiaozuo Zhongwei Special Products Pharmaceutical Copovidone VA 64 Product Overview
Table 92. Jiaozuo Zhongwei Special Products Pharmaceutical Copovidone VA 64 Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Jiaozuo Zhongwei Special Products Pharmaceutical Business Overview
Table 94. Jiaozuo Zhongwei Special Products Pharmaceutical Recent Developments
Table 95. Henan Pengfei New Materials Basic Information
Table 96. Henan Pengfei New Materials Copovidone VA 64 Product Overview
Table 97. Henan Pengfei New Materials Copovidone VA 64 Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Henan Pengfei New Materials Business Overview
Table 99. Henan Pengfei New Materials Recent Developments
Table 100. Shanxi Jinyang Pharmaceutical Excipients Basic Information
Table 101. Shanxi Jinyang Pharmaceutical Excipients Copovidone VA 64 Product Overview
Table 102. Shanxi Jinyang Pharmaceutical Excipients Copovidone VA 64 Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Shanxi Jinyang Pharmaceutical Excipients Business Overview
Table 104. Shanxi Jinyang Pharmaceutical Excipients Recent Developments
Table 105. Global Copovidone VA 64 Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global Copovidone VA 64 Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America Copovidone VA 64 Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America Copovidone VA 64 Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe Copovidone VA 64 Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe Copovidone VA 64 Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific Copovidone VA 64 Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific Copovidone VA 64 Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America Copovidone VA 64 Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America Copovidone VA 64 Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa Copovidone VA 64 Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa Copovidone VA 64 Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global Copovidone VA 64 Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global Copovidone VA 64 Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global Copovidone VA 64 Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global Copovidone VA 64 Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global Copovidone VA 64 Market Size Forecast by Application (2026-2035) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Copovidone VA 64
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Copovidone VA 64 Market Size (M USD), 2025-2035
Figure 5. Global Copovidone VA 64 Market Size (M USD) (2020-2035)
Figure 6. Global Copovidone VA 64 Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Copovidone VA 64 Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Copovidone VA 64 Product Life Cycle
Figure 13. Copovidone VA 64 Sales Share by Manufacturers in 2025
Figure 14. Global Copovidone VA 64 Revenue Share by Manufacturers in 2025
Figure 15. Copovidone VA 64 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Copovidone VA 64 Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Copovidone VA 64 Revenue in 2025
Figure 18. Industry Chain Map of Copovidone VA 64
Figure 19. Global Copovidone VA 64 Market PEST Analysis
Figure 20. Global Copovidone VA 64 Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Copovidone VA 64 Market Share by Type
Figure 27. Sales Market Share of Copovidone VA 64 by Type (2020-2025)
Figure 28. Sales Market Share of Copovidone VA 64 by Type in 2025
Figure 29. Market Share of Copovidone VA 64 by Type (2020-2025)
Figure 30. Market Share of Copovidone VA 64 by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Copovidone VA 64 Market Share by Application
Figure 33. Global Copovidone VA 64 Sales Market Share by Application (2020-2025)
Figure 34. Global Copovidone VA 64 Sales Market Share by Application in 2025
Figure 35. Global Copovidone VA 64 Market Share by Application (2020-2025)
Figure 36. Global Copovidone VA 64 Market Share by Application in 2025
Figure 37. Global Copovidone VA 64 Sales Growth Rate by Application (2020-2025)
Figure 38. Global Copovidone VA 64 Sales Market Share by Region (2020-2025)
Figure 39. Global Copovidone VA 64 Market Size by Region (2020-2025)
Figure 40. North America Copovidone VA 64 Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Copovidone VA 64 Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Copovidone VA 64 Sales Market Share by Country in 2024
Figure 43. North America Copovidone VA 64 Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Copovidone VA 64 Market Size by Country in 2024
Figure 45. U.S. Copovidone VA 64 Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Copovidone VA 64 Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Copovidone VA 64 Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Copovidone VA 64 Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Copovidone VA 64 Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Copovidone VA 64 Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Copovidone VA 64 Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Copovidone VA 64 Sales Market Share by Country in 2024
Figure 53. Europe Copovidone VA 64 Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Copovidone VA 64 Market Size by Country in 2024
Figure 55. Germany Copovidone VA 64 Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Copovidone VA 64 Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Copovidone VA 64 Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Copovidone VA 64 Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Copovidone VA 64 Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Copovidone VA 64 Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Copovidone VA 64 Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Copovidone VA 64 Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Copovidone VA 64 Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Copovidone VA 64 Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Copovidone VA 64 Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Copovidone VA 64 Sales Market Share by Region in 2024
Figure 67. Asia Pacific Copovidone VA 64 Market Size by Region in 2024
Figure 68. China Copovidone VA 64 Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Copovidone VA 64 Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Copovidone VA 64 Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Copovidone VA 64 Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Copovidone VA 64 Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Copovidone VA 64 Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Copovidone VA 64 Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Copovidone VA 64 Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Copovidone VA 64 Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Copovidone VA 64 Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Copovidone VA 64 Sales and Growth Rate (K MT)
Figure 79. South America Copovidone VA 64 Sales Market Share by Country in 2024
Figure 80. South America Copovidone VA 64 Market Size and Growth Rate (M USD)
Figure 81. South America Copovidone VA 64 Market Size by Country in 2024
Figure 82. Brazil Copovidone VA 64 Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Copovidone VA 64 Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Copovidone VA 64 Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Copovidone VA 64 Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Copovidone VA 64 Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Copovidone VA 64 Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Copovidone VA 64 Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Copovidone VA 64 Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Copovidone VA 64 Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Copovidone VA 64 Market Size by Region in 2024
Figure 92. Saudi Arabia Copovidone VA 64 Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Copovidone VA 64 Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Copovidone VA 64 Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Copovidone VA 64 Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Copovidone VA 64 Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Copovidone VA 64 Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Copovidone VA 64 Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Copovidone VA 64 Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Copovidone VA 64 Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Copovidone VA 64 Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Copovidone VA 64 Production Market Share by Region (2020-2025)
Figure 103. North America Copovidone VA 64 Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Copovidone VA 64 Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Copovidone VA 64 Production (K MT) Growth Rate (2020-2025)
Figure 106. China Copovidone VA 64 Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Copovidone VA 64 Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Copovidone VA 64 Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Copovidone VA 64 Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Copovidone VA 64 Market Share Forecast by Type (2026-2035)
Figure 111. Global Copovidone VA 64 Sales Forecast by Application (2026-2035)
Figure 112. Global Copovidone VA 64 Market Share Forecast by Application (2026-2035)


More Publications